T 1759/17 (Evaluation of immune response to therapeutic protein/BIOGEN) of 29.03.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T175917.20220329
- Date of decision
- 29 March 2022
- Case number
- T 1759/17
- Petition for review of
- -
- Application number
- 06749243.9
- IPC class
- G01N 33/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHODS AND PRODUCTS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC PROTEIN
- Applicant name
- Biogen MA Inc.
- Opponent name
- Urquhart-Dykes & Lord LLP
Pharmaceutical Works Polpharma SA - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Amendment to appeal case
Amendment after summons - taken into account (no)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.